BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 22360334)

  • 1. Advances in the use of botulinum neurotoxins in facial esthetics.
    Flynn TC
    J Cosmet Dermatol; 2012 Mar; 11(1):42-50. PubMed ID: 22360334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IncobotulinumtoxinA in esthetics.
    Kerscher M; Yutskovskaya Y; Flynn TC
    J Drugs Dermatol; 2013 Jun; 12(6):e111-20. PubMed ID: 23839200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
    Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part I: Upper facial wrinkles.
    Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1278-84. PubMed ID: 20337830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of type A botulinum toxins for aesthetic indications and their relative economic impact.
    Jandhyala R
    J Plast Reconstr Aesthet Surg; 2012 Jun; 65(6):720-31. PubMed ID: 22225675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative potency of incobotulinumtoxinA vs onabotulinumtoxinA a meta-analysis of key evidence.
    Jandhyala R
    J Drugs Dermatol; 2012 Jun; 11(6):731-6. PubMed ID: 22648220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)--Part II: Wrinkles on the middle and lower face, neck and chest.
    Ascher B; Talarico S; Cassuto D; Escobar S; Hexsel D; Jaén P; Monheit GD; Rzany B; Viel M
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1285-95. PubMed ID: 20569284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of Botulinum Toxins for Aesthetic Uses.
    Gart MS; Gutowski KA
    Clin Plast Surg; 2016 Jul; 43(3):459-71. PubMed ID: 27363760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A for aging face and aesthetic uses.
    Hexsel C; Hexsel D; Porto MD; Schilling J; Siega C
    Dermatol Ther; 2011; 24(1):54-61. PubMed ID: 21276158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the spread of three botulinum toxin type A preparations.
    Kerscher M; Roll S; Becker A; Wigger-Alberti W
    Arch Dermatol Res; 2012 Mar; 304(2):155-61. PubMed ID: 22002325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum neurotoxin A: a review.
    Berry MG; Stanek JJ
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1283-91. PubMed ID: 22552262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content of botulinum neurotoxin in Botox®/Vistabel®, Dysport®/Azzalure®, and Xeomin®/Bocouture®.
    Frevert J
    Drugs R D; 2010; 10(2):67-73. PubMed ID: 20698714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Quantitative Analysis of OnabotulinumtoxinA, AbobotulinumtoxinA, and IncobotulinumtoxinA: A Randomized, Double-Blind, Prospective Clinical Trial of Comparative Dynamic Strain Reduction.
    Wilson AJ; Chang B; Taglienti AJ; Chin BC; Chang CS; Folsom N; Percec I
    Plast Reconstr Surg; 2016 May; 137(5):1424-1433. PubMed ID: 27119918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correcting age-related changes in the face by use of injectable fillers and neurotoxins.
    Rubin MG; Cox SE; Kaminer MS; Solish N
    Semin Cutan Med Surg; 2014 Jun; 33(4 Suppl):S81-4. PubMed ID: 25268602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin (Botox) to enhance facial macroesthetics: a literature review.
    Dastoor SF; Misch CE; Wang HL
    J Oral Implantol; 2007; 33(3):164-71. PubMed ID: 17674683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping.
    Fagien S
    Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):6S-18S; discussion 19S-20S. PubMed ID: 14504481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of IncobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot study.
    Gubanova EI; Panova OS; Sanchez EA; Rodina MY; Starovatova PA
    J Drugs Dermatol; 2013 Dec; 12(12):1461-6. PubMed ID: 24301249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendations.
    Kane M; Donofrio L; Ascher B; Hexsel D; Monheit G; Rzany B; Weiss R
    J Drugs Dermatol; 2010 Jan; 9(1 Suppl):s7-22; quiz s23-5. PubMed ID: 20919448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.